MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

8 FDA-Blessed Wearables and Apps Changing Healthcare - BodyGuardian

Article-8 FDA-Blessed Wearables and Apps Changing Healthcare - BodyGuardian

 Product Name: BodyGuardian Heart Remote Patient Monitoring SystemDescription: BlueStar is the first mobile prescription therapy that is cleared by the FDA to help type 2 diabetes patients manage their disease. 

Product Name: BodyGuardian Heart Remote Patient Monitoring System

Company: Preventice Solutions

Description: The BodyGuardian Heart Remote Patient Monitoring System is intended to provide ECG data on patients who are able to be up and about as well as provide details on their respiration rate and activity levels if used in conjunction with the associated patient portal.

Developed in partnershp with the the Mayo Clinic, the system comrises a smal, chest-worn sensor that is applied with a disposable strip. The device can help to detect arrhythmmia in aysmptomatic patients and can be remotely programmed to capture and transmit the data. The wearable device can transmit data to an app on the smartphone for patients. Meanwhile doctors can access that same data through the web using the company's PatientView and PatientFlow portals.

In August 2015, Boston Scientific became an investor in Preventice Solutions as well as its exclusive worldwide sales and marketing representative for the company's cardiology-related diagnostic and monitoring offerings.

FDA Clearance: 2012

TAGS: News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.